<?xml version="1.0" encoding="UTF-8"?>
<ref id="B264" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Sima</surname>
    <given-names class="given-names">F.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Stratakos</surname>
    <given-names class="given-names">A. C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ward</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Linton</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kelly</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pinkerton</surname>
    <given-names class="given-names">L.</given-names>
   </name>
   <etal class="etal"/>
  </person-group> (
  <year class="year">2018</year>). 
  <article-title class="article-title">A novel natural antimicrobial can reduce the 
   <italic class="italic">in vitro</italic> and 
   <italic class="italic">in vivo</italic> pathogenicity of T6SS positive 
   <italic class="italic">Campylobacter jejuni</italic> and 
   <italic class="italic">Campylobacter coli</italic> chicken isolates.
  </article-title>
  <source class="source">
   <italic class="italic">Front. Microbiol.</italic>
  </source>
  <volume class="volume">9</volume>:
  <issue class="issue">2139</issue>. 
  <pub-id pub-id-type="doi" class="pub-id">10.3389/fmicb.2018.02139</pub-id>
  <?supplied-pmid 30245680?>
  <pub-id pub-id-type="pmid" class="pub-id">30245680</pub-id>
 </mixed-citation>
</ref>
